GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery, has ...

Clearance of ASC50 paves the way for a Phase I trial in patients with mild-to-moderate plaque psoriasis.

Expansion of Predictive's AI-driven drug discovery platform to include biomarker discovery and drug repurposing, positioning the company to capitalize on a rapidly growing market projected at $14. ...

Tell us about the product or service that Inductive Bio offers.

PITTSBURGH, May 20, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today issued the following shareholder update recapping recent progress: ...

Following the presentation titled 'Discovering Targeted Glue™ degraders with Amphista's Eclipsys® platform', Simon Gilbert, PhD, Presenting Author and Associate Director Discovery Biology at Amphista ...

Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...

SINGAPORE] Imagine a world where life-saving treatments are discovered not in decades, but in just a few years. Nanyang ...

While AI-generated drugs grab headlines, the technology is making more of an impact doing less “glamorous” tasks.

successfully held the AIDD platform launch event "Enchantment of Drug Discovery", unveiling the advanced and comprehensive AI-Driven Drug Discovery (AIDD) platform to the industry. During the event, ...